• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨骼肌Ca2+通道α1亚基内苯烷基胺结合区域的鉴定。

Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.

作者信息

Striessnig J, Glossmann H, Catterall W A

机构信息

Department of Pharmacology, University of Washington, Seattle 98195.

出版信息

Proc Natl Acad Sci U S A. 1990 Dec;87(23):9108-12. doi: 10.1073/pnas.87.23.9108.

DOI:10.1073/pnas.87.23.9108
PMID:2174553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC55113/
Abstract

The alpha 1 subunit of the skeletal muscle Ca2+ channel has been specifically photoaffinity labeled with the phenylalkylamine-receptor-selective verapamil derivative (-)-5-(3-azidophenethyl[N-methyl-3H]methylamino)-2-(3,4,5- trimethoxyphenyl)-2-isopropylvaleronitrile ([N-methyl-3H]LU49888). Proteolytic fragments generated by various endoproteases were probed by immunoprecipitation with several sequence-specific antibodies to determine the site of labeling within the primary structure of alpha 1. These results restrict the site of photolabeling by [N-methyl-3H]LU49888 to the region between Glu-1349 and Trp-1391. This segment of alpha 1 contains transmembrane helix S6 of domain IV and the beginning of the long intracellular C-terminal tail. Because of the phenylalkylamine receptor site is only accessible from the intracellular side of the Ca2+ channel, we propose that the intracellular end of helix IVS6 and the adjacent intracellular amino acid residues play an essential role in formation of the phenylalkylamine receptor site. The action of the phenylalkylamines as open-channel blockers suggests that this region may also contribute to formation of the intracellular opening of the transmembrane pore of the Ca2+ channel.

摘要

骨骼肌钙离子通道的α1亚基已被用苯烷基胺受体选择性维拉帕米衍生物(-)-5-(3-叠氮苯乙基[N-甲基-3H]甲氨基)-2-(3,4,5-三甲氧基苯基)-2-异丙基戊腈([N-甲基-3H]LU49888)进行特异性光亲和标记。通过用几种序列特异性抗体进行免疫沉淀,对各种内切蛋白酶产生的蛋白水解片段进行检测,以确定α1一级结构中的标记位点。这些结果将[N-甲基-3H]LU49888的光标记位点限制在Glu-1349和Trp-1391之间的区域。α1的这一片段包含结构域IV的跨膜螺旋S6和长的细胞内C末端尾巴的起始部分。由于苯烷基胺受体位点仅从钙离子通道的细胞内侧可及,我们提出螺旋IVS6的细胞内末端和相邻的细胞内氨基酸残基在苯烷基胺受体位点的形成中起重要作用。苯烷基胺作为开放通道阻滞剂的作用表明,该区域也可能有助于钙离子通道跨膜孔细胞内开口的形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/5697fd741040/pnas01048-0048-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/6b59be1229fc/pnas01048-0046-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/45ca61552067/pnas01048-0046-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/03ea0ea3c1eb/pnas01048-0047-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/337cf07d702d/pnas01048-0048-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/5697fd741040/pnas01048-0048-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/6b59be1229fc/pnas01048-0046-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/45ca61552067/pnas01048-0046-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/03ea0ea3c1eb/pnas01048-0047-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/337cf07d702d/pnas01048-0048-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f87f/55113/5697fd741040/pnas01048-0048-b.jpg

相似文献

1
Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.骨骼肌Ca2+通道α1亚基内苯烷基胺结合区域的鉴定。
Proc Natl Acad Sci U S A. 1990 Dec;87(23):9108-12. doi: 10.1073/pnas.87.23.9108.
2
Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.L型Ca2+通道的二氢吡啶受体:α1亚基内[3H](+)-PN200-110和[3H]叠氮平结合域的鉴定。
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10769-73. doi: 10.1073/pnas.88.23.10769.
3
Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.通过用二氮嗪进行光亲和标记鉴定骨骼肌Ca2+通道α1亚基内的1,4-二氢吡啶结合区域。
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9203-7. doi: 10.1073/pnas.88.20.9203.
4
Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.豚鼠海马体中钙通道相关的1,4 - 二氢吡啶和苯烷基胺受体的光亲和标记。一种195 kDa的多肽同时携带这两种药物受体,并且与纯化的骨骼肌钙通道的α1亚基具有相似性。
Biochem J. 1988 Jul 1;253(1):39-47. doi: 10.1042/bj2530039.
5
Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel.
FEBS Lett. 1987 Feb 23;212(2):247-53. doi: 10.1016/0014-5793(87)81354-6.
6
Azidobutyryl clentiazem, a new photoactivatable diltiazem analog, labels benzothiazepine binding sites in the alpha 1 subunit of the skeletal muscle calcium channel.叠氮丁酰地尔硫䓬,一种新型的可光活化的地尔硫䓬类似物,可标记骨骼肌钙通道α1亚基中的苯并硫氮䓬结合位点。
FEBS Lett. 1993 Nov 22;334(3):261-4. doi: 10.1016/0014-5793(93)80690-v.
7
Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the alpha1 subunit.跨膜区IIIS6及α1亚基孔区中L型钙通道高亲和力苯烷基胺阻断的分子决定因素。
J Biol Chem. 1997 Jul 25;272(30):18759-65. doi: 10.1074/jbc.272.30.18759.
8
Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations.在钙通道制剂中鉴定一种新型的与1,4 - 二氢吡啶和苯烷基胺结合的多肽。
J Biol Chem. 1987 Oct 15;262(29):14337-42.
9
Rabbit skeletal muscle microsomes contain two distinct phenylalkylamine-binding sites.兔骨骼肌微粒体含有两个不同的苯烷基胺结合位点。
Eur J Biochem. 1988 Feb 15;172(1):233-8. doi: 10.1111/j.1432-1033.1988.tb13878.x.
10
Photoaffinity labeling of the purified skeletal muscle calcium antagonist receptor by a novel benzothiazepine, [3H]azidobutyryl diltiazem.
J Biol Chem. 1989 Dec 15;264(35):21211-4.

引用本文的文献

1
A tale of two calcium channels: structural pharmacology of Cav2.1 and Cav3.2.两种钙通道的故事:Cav2.1和Cav3.2的结构药理学
Cell Res. 2024 Jun;34(6):401-402. doi: 10.1038/s41422-024-00961-0.
2
Voltage gated sodium and calcium channels: Discovery, structure, function, and Pharmacology.电压门控钠离子和钙离子通道:发现、结构、功能和药理学。
Channels (Austin). 2023 Dec;17(1):2281714. doi: 10.1080/19336950.2023.2281714. Epub 2023 Nov 20.
3
Duplex signaling by CaM and Stac3 enhances Ca1.1 function and provides insights into congenital myopathy.

本文引用的文献

1
Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules.从骨骼肌横管中纯化电压敏感性钙通道的钙拮抗剂受体。
Biochemistry. 1984 May 8;23(10):2113-8. doi: 10.1021/bi00305a001.
2
Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane?有机钙通道阻滞剂D600是在心肌细胞膜内侧还是外侧发挥作用?
Pflugers Arch. 1982 Jun;393(4):287-91. doi: 10.1007/BF00581411.
3
(-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
钙调蛋白和 Stac3 的双信号增强 Ca1.1 功能,并为先天性肌病提供了新的见解。
J Gen Physiol. 2018 Aug 6;150(8):1145-1161. doi: 10.1085/jgp.201812005. Epub 2018 Jun 27.
4
Structural basis for inhibition of a voltage-gated Ca channel by Ca antagonist drugs.钙拮抗剂药物对电压门控钙通道的抑制作用的结构基础。
Nature. 2016 Sep 1;537(7618):117-121. doi: 10.1038/nature19102. Epub 2016 Aug 24.
5
Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders.精神疾病和神经疾病中电压门控钙通道的基因破坏。
Prog Neurobiol. 2015 Nov;134:36-54. doi: 10.1016/j.pneurobio.2015.09.002. Epub 2015 Sep 16.
6
Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels.电压门控钠通道和钙通道药理学的结构基础
Mol Pharmacol. 2015 Jul;88(1):141-50. doi: 10.1124/mol.114.097659. Epub 2015 Apr 6.
7
Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure.原型钙通道阻滞剂在美沙酮维持的人类中对纳洛酮辨别程序的反应的影响。
Eur J Pharmacol. 2013 Sep 5;715(1-3):424-35. doi: 10.1016/j.ejphar.2013.03.007. Epub 2013 Mar 21.
8
Identification and analysis of cation channel homologues in human pathogenic fungi.鉴定和分析人类病原真菌中的阳离子通道同源物。
PLoS One. 2012;7(8):e42404. doi: 10.1371/journal.pone.0042404. Epub 2012 Aug 2.
9
Blockade of I(Ca) suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failure.阻断 I(Ca) 可抑制慢性心力衰竭全心模型中的早期后除极,并减少复极的跨壁离散度。
Br J Pharmacol. 2012 May;166(2):557-68. doi: 10.1111/j.1476-5381.2011.01721.x.
10
Presynaptic calcium channels and α3-integrins are complexed with synaptic cleft laminins, cytoskeletal elements and active zone components.突触前钙离子通道和 α3 整合素与突触小裂隙层粘连蛋白、细胞骨架成分和活性区成分复合。
J Neurochem. 2010 Nov;115(3):654-66. doi: 10.1111/j.1471-4159.2010.06965.x. Epub 2010 Sep 28.
FEBS Lett. 1984 Oct 29;176(2):371-7. doi: 10.1016/0014-5793(84)81199-0.
4
Primary structure of the receptor for calcium channel blockers from skeletal muscle.骨骼肌中钙通道阻滞剂受体的一级结构。
Nature. 1987;328(6128):313-8. doi: 10.1038/328313a0.
5
Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.猫心脏中1,4 - 二氢吡啶和苯烷基胺类钙通道阻滞剂的负性肌力作用强度与结合参数之间的相关性
Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):303-12. doi: 10.1007/BF00508786.
6
Calcium channels: molecular pharmacology, structure and regulation.钙通道:分子药理学、结构与调控
J Membr Biol. 1988 Sep;104(2):81-105. doi: 10.1007/BF01870922.
7
Site of covalent attachment of alpha-scorpion toxin derivatives in domain I of the sodium channel alpha subunit.α-蝎毒素衍生物在钠通道α亚基结构域I中的共价连接位点。
Proc Natl Acad Sci U S A. 1988 Nov;85(22):8742-6. doi: 10.1073/pnas.85.22.8742.
8
A single point mutation confers tetrodotoxin and saxitoxin insensitivity on the sodium channel II.一个单点突变使钠通道II对河豚毒素和石房蛤毒素不敏感。
FEBS Lett. 1989 Dec 18;259(1):213-6. doi: 10.1016/0014-5793(89)81531-5.
9
Subunits of purified calcium channels: a 212-kDa form of alpha 1 and partial amino acid sequence of a phosphorylation site of an independent beta subunit.纯化钙通道的亚基:一种212 kDa形式的α1以及一个独立β亚基磷酸化位点的部分氨基酸序列。
Proc Natl Acad Sci U S A. 1989 Nov;86(21):8585-9. doi: 10.1073/pnas.86.21.8585.
10
Mutant potassium channels with altered binding of charybdotoxin, a pore-blocking peptide inhibitor.与孔道阻断肽抑制剂蝎毒素结合改变的突变钾通道。
Science. 1989 Sep 22;245(4924):1382-5. doi: 10.1126/science.2476850.